Ann N Y Acad Sci
-
Publication Venue For
- Transient receptor potential channels in pulmonary chemical injuries and as countermeasure targets.. 1480:73-103. 2020
- Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease?. 1461:25-36. 2020
- Vaccine innovations for emerging infectious diseases-a symposium report.. 1462:14-26. 2020
- Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging.. 1442:48-60. 2019
- Comparative effectiveness clinical trials to advance treatment of myasthenia gravis.. 1413:69-75. 2018
- Developing treatment guidelines for myasthenia gravis.. 1412:95-101. 2018
- Disease drivers of aging.. 1386:45-68. 2016
- Personalized and targeted therapy of esophageal squamous cell carcinoma: an update.. 1381:66-73. 2016
- Tear gas: an epidemiological and mechanistic reassessment.. 1378:96-107. 2016
- Effects of a block in cysteine catabolism on energy balance and fat metabolism in mice.. 1363:99-115. 2016
- One-carbon metabolism and epigenetics: understanding the specificity.. 1363:91-98. 2016
- New functions and signaling mechanisms for the class of adhesion G protein-coupled receptors.. 1333:43-64. 2014
- Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.. 1300:187-199. 2013
- Application of combined omics platforms to accelerate biomedical discovery in diabesity.. 1287:1-16. 2013
- Hypoxia-induced phrenic long-term facilitation: emergent properties.. 1279:143-153. 2013
- Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.. 1275:17-22. 2012
- Patient registries: useful tools for clinical research in myasthenia gravis.. 1274:107-113. 2012
- Brain stimulation in neurology and psychiatry: perspectives on an evolving field.. 1265:vii-x. 2012
- Increasing the validity of experimental models for depression.. 1265:36-45. 2012
- The ethics of research on deep brain stimulation for depression: decisional capacity and therapeutic misconception.. 1265:69-79. 2012
- Mouse models for studying genetic influences on factors determining smoking cessation success in humans.. 1248:39-70. 2012
- New and emerging disease modifying therapies for multiple sclerosis.. 1247:117-137. 2012
- Advancing drug discovery for schizophrenia.. 1236:30-43. 2011
- Potential mechanisms for reduced delivery of nitric oxide to peripheral tissues in diabetes mellitus.. 1203:101-106. 2010
- Transient receptor potential vanilloid 4: The sixth sense of the musculoskeletal system?. 1192:404-409. 2010
- B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer.. 1183:38-57. 2010
- Antidote-controlled antithrombotic therapy targeting factor IXa and von Willebrand factor.. 1175:61-70. 2009
- Chemoreception scientists gather under the Florida sun: The 31st Annual Association for Chemoreception Sciences meeting.. 1170 Suppl 1:1-11. 2009
- Trafficking of mammalian chemosensory receptors by receptor-transporting proteins.. 1170:153-156. 2009
- Progress in the understanding of the genetic etiology of vertebral segmentation disorders in humans.. 1151:38-67. 2009
- The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration.. 1147:61-69. 2008
- Gastrin-releasing peptide, immune responses, and lung disease.. 1144:136-147. 2008
- Molecular mechanisms of TRPV4-mediated neural signaling.. 1144:42-52. 2008
- Parathyroid hormone-related protein regulates glioma-associated oncogene transcriptional activation: lessons learned from bone development and cartilage neoplasia.. 1144:36-41. 2008
- ADHD and smoking: from genes to brain to behavior.. 1141:131-147. 2008
- Disrupting nicotine reinforcement: from cigarette to brain.. 1141:233-256. 2008
- Does Meditation Enhance Cognition and Brain Longevity? 2007
- Functional Assessment of the Efficacy of Oxygen Free Radical Scavengers in the "No-Reflow" Phenomenon in Skeletal Muscle.. 723:418-419. 1994
- Prevention of Reperfusion Injury in Skeletal Muscle.. 723:420-421. 1994